$11.14+0.50 (+4.70%)
News25/Ratings0
Latest news
25 items- PRMarketBeat Ranks Stocks with Most Insider Buying in June 2021SIOUX FALLS, S.D., July 8, 2021 /PRNewswire-PRWeb/ -- MarketBeat, a leading source for stock market data and research tools, has published a monthly list ranking The 10 Stocks with the Most Insider Buying in June 2021. An insider trade occurs when a company executive or individual who has non-public information about a company buys or sells shares of that company's stock. The level of stock that insiders are buying is a potential indicator of the stock's future performance. The MarketBeat editorial team compiled the 10 stocks with the most insider trading by utilizing the company's Stocks with the Most Insider Buying Report. For stocks with the most insider buying, software companies and s
- 13D/GSEC Form SC 13D filed by ARYA Sciences Acquisition Corp IIISC 13D - Nautilus Biotechnology, Inc. (0001808805) (Subject)
- SECSEC Form D filed by ARYA Sciences Acquisition Corp IIID - Nautilus Biotechnology, Inc. (0001808805) (Filer)
- 13D/GSEC Form SC 13D filed by ARYA Sciences Acquisition Corp IIISC 13D - Nautilus Biotechnology, Inc. (0001808805) (Subject)
- 13D/GSEC Form SC 13D filed by ARYA Sciences Acquisition Corp IIISC 13D - Nautilus Biotechnology, Inc. (0001808805) (Subject)
- 13D/GSEC Form SC 13D filed by ARYA Sciences Acquisition Corp IIISC 13D - Nautilus Biotechnology, Inc. (0001808805) (Subject)
- INSIDERSEC Form 4: PERCEPTIVE ADVISORS LLC bought $55,070,983 worth of Common Stock (5,507,063 units at $10.00), increasing direct ownership by 1% to 497,038 units4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
- INSIDERSEC Form 4: ALTMAN MICHAEL SETH converted 4,146,500 units into Common Stock4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
- SECARYA Sciences Acquisition Corp III filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Changes in Registrant’s Certifying Accountant, Financial Statements and Exhibits, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Amendments to the Registrant’s Code of Ethics, or Waiver of a Provision of the Code of Ethics, Change in Shell Company Status, Regulation FD Discl8-K - Nautilus Biotechnology, Inc. (0001808805) (Filer)
- PRNautilus Biotechnology Debuts as Publicly Traded Company, Seeks to Deliver on the Untapped Potential of the Human ProteomeBusiness combination transaction with Arya Sciences Acquisition Corp III, a special purpose acquisition company sponsored by Perceptive Advisors, closed on June 9, 2021Publicly traded company renamed Nautilus Biotechnology, Inc.Common stock commences trading under ticker symbol “NAUT” on the Nasdaq Global Select Market on June 10, 2021Gross proceeds from this transaction to Nautilus totaled approximately $345 million, combining approximately $145 million of funds held in Arya III’s trust account and a concurrent PIPE financing of $200 million SEATTLE and NEW YORK, June 09, 2021 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc., a company pioneering a single-molecule protein analysis pla
- INSIDERSEC Form 3 filed by Epperly Melissa B,3 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
- INSIDERSEC Form 3: Murphy Matthew B. claimed ownership of 29,140 units of Common Stock3 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
- INSIDERSEC Form 3: Mallick Parag claimed ownership of 20,689,892 units of Common Stock3 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
- INSIDERSEC Form 3 filed by ARYA Sciences Acquisition Corp III3 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
- INSIDERSEC Form 3 filed by ARYA Sciences Acquisition Corp III3 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
- INSIDERSEC Form 3: McIlwain Matthew S claimed ownership of 6,342,875 units of Common Stock3 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
- INSIDERSEC Form 3 filed by ARYA Sciences Acquisition Corp III3 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
- INSIDERSEC Form 3 filed by Nelson Nicholas A.3 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
- INSIDERSEC Form 3: Patel Sujal M claimed ownership of 16,708,899 units of Common Stock3 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
- INSIDERSEC Form 3 filed by Sankar Subramanian3 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
- INSIDERSEC Form 3: NAZEM FARZAD claimed ownership of 1,888,146 units of Common Stock3 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
- INSIDERSEC Form 3 filed by ARYA Sciences Acquisition Corp III3 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
- SECSEC Form 425 filed by ARYA Sciences Acquisition Corp III425 - ARYA Sciences Acquisition Corp III (0001808805) (Subject)
- SECARYA Sciences Acquisition Corp III filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - ARYA Sciences Acquisition Corp III (0001808805) (Filer)
- INSIDERSEC Form 4 filed by ARYA Sciences Acquisition Corp III4 - ARYA Sciences Acquisition Corp III (0001808805) (Issuer)
ARYA FAQ
5 questionsWhere does ARYA stock trade?
ARYA Sciences Acquisition Corp III (ARYA) is listed on NASDAQ.What sector and industry is ARYA in?
ARYA Sciences Acquisition Corp III operates in the Finance sector, Business Services industry.When did ARYA Sciences Acquisition Corp III go public?
ARYA Sciences Acquisition Corp III (ARYA) completed its IPO in 2020.What companies are similar to ARYA?
Notable peers in the same industry include FLT (FleetCor Technologies Inc.), NVEI (Nuvei Corporation Subordinate Voting Shares), NLSN (Nielsen N.V.), STMP (Stamps.com Inc.), ENV (Envestnet Inc). Compare ARYA side-by-side with any of them on Quantisnow.How can I track ARYA on Quantisnow?
Quantisnow aggregates ARYA Sciences Acquisition Corp III's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ARYA to receive live email and push alerts on every new disclosure.